3 March 2020 - On November 6, 2019, the Department of Health and Human Services (HHS) filed a lawsuit against Gilead ...
12 September 2019 - The American patent system has, since our nation's founding, served as a cornerstone of innovation. But ...
21 August 2019 - Gilead Sciences took the unusual step of mounting a challenge to U.S. government patents on Wednesday, ...
26 July 2019 - Medicines Australia supports efforts to strengthen Australia’s Intellectual Property arrangements to be consistent with international best ...
16 July 2019 - It does not seem to matter how angrily President Trump tweets, how pointedly House Speaker Nancy ...
18 June 2019 - A pair of law makers has asked the Government Accountability Office to review how the U.S. ...
7 May 2019 - If there was any hope that Congress might overhaul the way this country doles out the ...
1 May 2019 - U.S. trade deals increasingly include terms affecting the approval process and availability of medicines. ...
21 March 2019 - President Trump’s ability to get his revised North American Free Trade Agreement through Congress may hinge ...
11 February 2019 - In a perfect world, the system for conveying medications from their makers to patients should be ...
7 December 2018 - A rare point of consensus following the midterm elections is that Americans are adamant about lowering ...
30 November 2018 - AbbVie announced today patent license agreements with Pfizer over its proposed biosimilar adalimumab product. ...
6 November 2018 - AbbVie announced today patent license agreements with Momenta over its proposed biosimilar adalimumab product. ...
18 October 2018 - Agreements provide non-exclusive license to Fresenius Kabi for Humira related intellectual property in the U.S. effective 30 ...
17 October 2018 - Just look at Humira, which is keeping its U.S. monopoly as generics hit the European market. ...